These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 8701410

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Reactivation of coagulation after stopping infusions of recombinant hirudin and unfractionated heparin in unstable angina and myocardial infarction without ST elevation: results of a randomized trial. OASIS Pilot Study Investigators. Organization to Assess Strategies for Ischemic++ Syndromes.
    Flather MD, Weitz JI, Yusuf S, Pogue J, Sussex B, Campeau J, Gill J, Schuld R, Joyner CD, Morris AL, Lai C, Théroux P, Marquis JF, Chan YK, Venkatesh G, Jessel A.
    Eur Heart J; 2000 Sep; 21(17):1473-81. PubMed ID: 10952840
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Development of an anti-bleeding agent for recombinant hirudin induced skin bleeding in the pig.
    Dickneite G, Nicolay U, Friesen HJ, Reers M.
    Thromb Haemost; 1998 Jul; 80(1):192-8. PubMed ID: 9684809
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of recombinant factor VIIa, tranexamic acid and desmopressin to reduce prasugrel-related bleeding: A randomised, placebo-controlled study in a rabbit model.
    Bonhomme F, Lecompte T, Samama CM, Godier A, Fontana P.
    Eur J Anaesthesiol; 2018 Mar; 35(3):208-214. PubMed ID: 29334511
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Investigation of activated prothrombin complex concentrate as potential hirudin antidote in animal models.
    Diehl KH, Römisch J, Hein B, Jessel A, Ronneberger H, Pâques EP.
    Haemostasis; 1995 Mar; 25(4):182-92. PubMed ID: 7557657
    [Abstract] [Full Text] [Related]

  • 12. A recombinant hirudin (IK-HIR02) in healthy volunteers. I. Effects on coagulation parameters and bleeding time.
    Schenk JF, Glusa E, Radziwon P, Butti A, Markwardt F, Breddin HK.
    Haemostasis; 1996 Mar; 26(3):140-9. PubMed ID: 8738588
    [Abstract] [Full Text] [Related]

  • 13. Anti-thrombotic effects of CX-397, a recombinant hirudin analog, in a canine model of coronary artery thrombosis.
    Ohyama T, Hori T, Moriike M, Asano T, Hayashi H, Iwade K, Hosoda S.
    Thromb Haemost; 1998 Feb; 79(2):423-30. PubMed ID: 9493602
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of desmopressin effects on haemostasis in children with congenital bleeding disorders.
    Hanebutt FL, Rolf N, Loesel A, Kuhlisch E, Siegert G, Knoefler R.
    Haemophilia; 2008 May; 14(3):524-30. PubMed ID: 18284449
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of topical hirudin (Hirudex): a double-blind, placebo-controlled study.
    Stamenova PK, Marchetti T, Simeonov I.
    Eur Rev Med Pharmacol Sci; 2001 May; 5(2):37-42. PubMed ID: 11863317
    [Abstract] [Full Text] [Related]

  • 18. The inhibitory effect of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, compared with enoxaparin and r-hirudin on ex vivo thrombin generation in human plasma.
    Boström SL, Hansson GF, Sarich TC, Wolzt M.
    Thromb Res; 2004 May; 113(1):85-91. PubMed ID: 15081569
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.